Bilthoven Biologicals
Monique Aal has extensive experience in quality assurance and compliance within the pharmaceutical and biological sectors, currently serving as QA Operations Manager at Bilthoven Biologicals since June 2012, with previous roles as a senior and QA Compliance Officer. Monique's career began as a Research Technician at ID-DLO and Fort Dodge Animal Health, progressing to Bioprocess Developer at Solvay Pharmaceuticals. Monique also held the title of QA Compliance Officer at NVI and coordinated polio and MMR vaccine production. Monique holds a degree in Biomedical Chemistry from Hogeschool IJsselland and completed HAVO at Scholengemeenschap Holten, along with vocational education in laboratory techniques.
This person is not in any offices
Bilthoven Biologicals
About Bilthoven Biologicals Bilthoven Biologicals is a biopharmaceutical company which produces Inactivated Polio Vaccines (IPV), Tetanus Vaccines, Diphtheria-Tetanus-Polio Vaccines (DT-PV) and Bacillus Calmette-Guérin (BCG) for the treatment of bladder cancer. We deliver our vaccines to UNICEF, with which we support the World Health Organisation (WHO) to eradicate polio. Bilthoven Biologicals has been part of the Cyrus Poonawalla Group since 2012, the world’s largest vaccine producer and employs more than 500 employees. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/en/what-we-produce/report-side-effects/ Over Bilthoven Biologicals Bilthoven Biologicals is een biofarmaceutisch bedrijf dat geïnactiveerde polio vaccins (IPV), Tetanus vaccins, Difterie-Tetanus-Polio vaccins (DT-IPV) produceert en Bacillus Calmette-Guérin (BCG) voor de behandeling van blaaskanker. Wij leveren onze vaccins aan UNICEF, waarmee wij de Wereldgezondheidsorganisatie (WHO) ondersteunen bij het uitroeien van polio. Bilthoven Biologicals is sinds 2012 onderdeel van de Cyrus Poonawalla Group, de grootste vaccinproducent ter wereld en heeft ruim 500 medewerkers. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/wat-wij-maken/bijwerkingen-melden/